ASPREE Cancer Endpoints Study
Public ClinicalTrials.gov record NCT01968798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ASPREE Cancer Endpoint Study (ACES), an ancillary study of the ASPirin in the Prevention of Events in the Elderly (ASPREE) Study, will allow for the examination of the effect of daily low-dose aspirin (100 mg) compared to placebo, on specific DNA biomarkers and selected specific incident and recurrent cancer and metastases. The establishment of this ACES biobank will allow for the exploration of DNA-related molecular mechanisms of aspirin's protective effect against cancer, cancer associated mortality and metastases, using blood or saliva DNA specimens, urine, and tumor tissue.
Study identification
- NCT ID
- NCT01968798
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 14,500 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2013 (Type not available)
- Primary completion
- Jan 2019 (Actual)
- Completion
- Apr 2024 (Estimated)
- Last update posted
- Apr 5, 2021
2013 – 2024
United States locations
- U.S. sites
- 40
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Palo Alto Medical Foundation Research Institute | Palo Alto | California | 94301 | — |
| Howard University | Washington D.C. | District of Columbia | 20060 | — |
| University of Florida Department of Aging and Geriatrics | Gainesville | Florida | 32611 | — |
| Morehouse School of Medicine | Atlanta | Georgia | 30310 | — |
| Emory/ Atlanta VAMC | Atlanta | Georgia | 30322 | — |
| Georgia Health Sciences University | Augusta | Georgia | 30912 | — |
| Rush Alzheimer's Disease Center | Chicago | Illinois | 60612 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Kansas University Medical Center | Kansas City | Kansas | 66106 | — |
| Baton Rouge General | Baton Rouge | Louisiana | 70801 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Mary Bird Perkins Our Lady of the Lake Cancer Center | Baton Rouge | Louisiana | 70809 | — |
| Mary Bird Perkins St. Tammany Parish Hospital | Covington | Louisiana | 70433 | — |
| Mary Bird Perkins Terrebonne General Hospital | Houma | Louisiana | 70360 | — |
| LSU Health Sciences- New Orleans | New Orleans | Louisiana | 70112 | — |
| Tulane Medical Center | New Orleans | Louisiana | 70112 | — |
| LSU Health Sciences- Shreveport | Shreveport | Louisiana | 71130 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Detroit Clinical Research Center | Novi | Michigan | 48377 | — |
| HealthPartners Research Institute | Minneapolis | Minnesota | 55425 | — |
| Phalen Village Clinic | Saint Paul | Minnesota | 55106 | — |
| Central Jersey Medical Center | Elizabeth | New Jersey | 07202 | — |
| New Jersey Medical College | Newark | New Jersey | 07103 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Queens Cancer Medical Center | Queens | New York | 11432 | — |
| Wake Forest University Baptist Medical Center | Greensboro | North Carolina | 27408 | — |
| The Brody School of Medicine at ECU | Greenville | North Carolina | 27834 | — |
| Albert Einstein Medical Center | Philadelphia | Pennsylvania | 19141 | — |
| University of Pittsburgh Health Sciences Research Center | Pittsburgh | Pennsylvania | 15260 | — |
| Memorial Hospital of Rhode Island | Pawtucket | Rhode Island | 02860 | — |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38105 | — |
| Meharry Medical College | Nashville | Tennessee | 57208 | — |
| University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | 75390 | — |
| University of TX Medical Branch | Galveston | Texas | 77555 | — |
| Regional Academic Health Center | Harlingen | Texas | 78550 | — |
| UT Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01968798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01968798 live on ClinicalTrials.gov.